A detailed history of Rhumbline Advisers transactions in Cronos Group Inc. stock. As of the latest transaction made, Rhumbline Advisers holds 355 shares of CRON stock, worth $731. This represents 0.0% of its overall portfolio holdings.

Number of Shares
355
Previous 355 -0.0%
Holding current value
$731
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 09, 2024

SELL
$1.93 - $2.7 $829 - $1,161
-430 Reduced 54.78%
355 $0
Q2 2023

Aug 08, 2023

BUY
$1.67 - $2.04 $1,310 - $1,601
785 New
785 $1,000

Others Institutions Holding CRON

About Cronos Group Inc.


  • Ticker CRON
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 377,896,000
  • Market Cap $778M
  • Description
  • Cronos Group Inc. operates as a cannabinoid company. It manufactures, markets, and distributes hemp-derived supplements and cosmetic products through e-commerce, retail, and hospitality partner channels under the Lord Jones and Happy Dance brands in the United States. The company is also involved in the cultivation, manufacture, and marketing of...
More about CRON
Track This Portfolio

Track Rhumbline Advisers Portfolio

Follow Rhumbline Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.